Maneka Mirchandaney

Stock Analyst at Evercore ISI Group

(0.26)
# 4,343
Out of 5,044 analysts
7
Total ratings
28.57%
Success rate
-28.86%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maneka Mirchandaney

Crinetics Pharmaceuticals
Sep 11, 2023
Maintains: Outperform
Price Target: $41$48
Current: $42.06
Upside: +14.12%
MiNK Therapeutics
Mar 22, 2023
Maintains: Outperform
Price Target: $40$30
Current: $14.20
Upside: +111.34%
Incyte
Aug 3, 2022
Downgrades: In-Line
Price Target: $90$78
Current: $91.65
Upside: -14.89%
Viridian Therapeutics
Oct 12, 2021
Initiates: Outperform
Price Target: $40
Current: $23.17
Upside: +72.64%
Werewolf Therapeutics
May 25, 2021
Initiates: Outperform
Price Target: $23
Current: $1.62
Upside: +1,319.75%